首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1349445篇
  免费   102666篇
  国内免费   5342篇
耳鼻咽喉   17122篇
儿科学   43836篇
妇产科学   36770篇
基础医学   198807篇
口腔科学   36327篇
临床医学   130984篇
内科学   258571篇
皮肤病学   26909篇
神经病学   112628篇
特种医学   48948篇
外国民族医学   379篇
外科学   186691篇
综合类   32323篇
一般理论   477篇
预防医学   114507篇
眼科学   29884篇
药学   100663篇
  15篇
中国医学   4144篇
肿瘤学   77468篇
  2019年   12257篇
  2018年   16902篇
  2017年   12970篇
  2016年   13830篇
  2015年   16087篇
  2014年   22117篇
  2013年   33249篇
  2012年   46157篇
  2011年   48823篇
  2010年   28199篇
  2009年   25864篇
  2008年   44101篇
  2007年   46485篇
  2006年   46528篇
  2005年   44972篇
  2004年   42526篇
  2003年   40299篇
  2002年   38994篇
  2001年   61298篇
  2000年   62950篇
  1999年   52520篇
  1998年   14067篇
  1997年   12572篇
  1996年   12397篇
  1995年   12616篇
  1994年   11774篇
  1993年   10972篇
  1992年   41719篇
  1991年   40960篇
  1990年   39622篇
  1989年   37506篇
  1988年   34704篇
  1987年   33798篇
  1986年   32269篇
  1985年   30731篇
  1984年   23064篇
  1983年   19567篇
  1982年   11722篇
  1981年   10260篇
  1979年   20815篇
  1978年   14811篇
  1977年   12046篇
  1976年   11847篇
  1975年   12093篇
  1974年   14796篇
  1973年   14475篇
  1972年   13375篇
  1971年   12413篇
  1970年   11487篇
  1969年   10426篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
American Indian and Alaska Native (AIAN) individuals are diverse culturally and geographically but share a high prevalence of chronic illness, largely because of obstacles to high-quality health care. The authors comprehensively examined cancer incidence and mortality among non-Hispanic AIAN individuals, compared with non-Hispanic White individuals for context, using population-based data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries. Overall cancer rates among AIAN individuals were 2% higher than among White individuals for incidence (2014 through 2018, confined to Purchased/Referred Care Delivery Area counties to reduce racial misclassification) but 18% higher for mortality (2015 through 2019). However, disparities varied widely by cancer type and geographic region. For example, breast and prostate cancer mortality rates are 8% and 31% higher, respectively, in AIAN individuals than in White individuals despite lower incidence and the availability of early detection tests for these cancers. The burden among AIAN individuals is highest for infection-related cancers (liver, stomach, and cervix), for kidney cancer, and for colorectal cancer among indigenous Alaskans (91.3 vs. 35.5 cases per 100,000 for White Alaskans), who have the highest rates in the world. Steep increases for early onset colorectal cancer, from 18.8 cases per 100,000 Native Alaskans aged 20–49 years during 1998 through 2002 to 34.8 cases per 100,000 during 2014 through 2018, exacerbated this disparity. Death rates for infection-related cancers (liver, stomach, and cervix), as well as kidney cancer, were approximately two-fold higher among AIAN individuals compared with White individuals. These findings highlight the need for more effective strategies to reduce the prevalence of chronic oncogenic infections and improve access to high-quality cancer screening and treatment for AIAN individuals. Mitigating the disparate burden will require expanded financial support of tribal health care as well as increased collaboration and engagement with this marginalized population.  相似文献   
2.
The analysis of mismatch repair proteins in solid tissue is the standard of care (SoC) for the microsatellite instability (MSI) characterization in endometrial cancer (EC). Uterine aspirates (UAs) or circulating-DNA (cfDNA) samples capture the intratumor heterogeneity and provide a more comprehensive and dynamic molecular diagnosis. Thus, MSI analysis by droplet-digital PCR (ddPCR) in UAs and cfDNA can provide a reliable tool to characterize and follow-up the disease. The UAs, paraffin-embedded tumor tissue (FFPE) and longitudinal plasma samples from a cohort of 90 EC patients were analyzed using ddPCR panel and compared to the SoC. A high concordance (96.67%) was obtained between the analysis of MSI markers in UAs and the SoC. Three discordant cases were validated as unstable by ddPCR on FFPE samples. Besides, a good overall concordance (70.27%) was obtained when comparing the performance of the ddPCR assay on UAs and cfDNA in high-risk tumors. Importantly, our results also evidenced the value of MSI analysis to monitor the disease evolution. MSI evaluation in minimally invasive samples shows great accuracy and sensitivity and provides a valuable tool for the molecular characterization and follow-up of endometrial tumors, opening new opportunities for personalized management of EC.  相似文献   
3.
4.
Spindler  L.  Alam  A.  Fathallah  N.  Rentien  A.-L.  Draullette  M.  Pommaret  E.  Thierry  M.-L.  Mituialy  A. El  Abbes  L.  Aubert  M.  Benfredj  P.  Far  E. Safa  Beaussier  H.  de Parades  V. 《Techniques in coloproctology》2022,26(2):143-146
Techniques in Coloproctology - The aim of our study was to assess the efficacy of sinus laser therapy (SiLaT) for the treatment of pilonidal disease. All adult patients treated with SiLaT in our...  相似文献   
5.
6.
随着低剂量螺旋电子计算机断层扫描(computed tomography,CT)应用于肺癌高危人群中的筛查越来越普及,肺外周病变(peripheral pulmonary lesions,PPLs)发现概率也随之增加。电磁导航支气管镜(electromagnetic navigation bronchoscopy,ENB)是一种能够进行肺部外周病变诊断、定位及治疗的工具,由于它的安全性和可靠性更高,ENB在未来有可能会改变肺部疾病的诊断和治疗方式,从而缓解病情甚至治愈肺癌,为肺癌的治疗开辟了新的路径。  相似文献   
7.
目的探讨辅助生殖技术中女方经阴道超声取卵手术导致泌尿系损伤的临床特点及诊断、处理措施。方法回顾性分析广西壮族自治区生殖医院2012年至2020年辅助生殖技术女方取卵手术中发生泌尿系损伤的临床资料、疾病类型、发现时机、诊治情况、预后及处理措施。结果 44 144例取卵手术中,发生泌尿系损伤20例,发生率为0.045%。其中膀胱损伤19例,输尿管损伤1例。在膀胱损伤中,术中发现1例,术后发现18例,输尿管损伤为术后发现。其中有8例是在进行了胚胎移植术后才发现,最终有4例获得妊娠。全部的病例经对症处理、膀胱冲洗和(或)膀胱镜检查、止血等治疗后,均痊愈。结论在辅助生殖技术中女方取卵手术损伤虽小,但要注意防范泌尿系损伤发生的风险,及时发现并处理,利于辅助生殖技术的后续治疗。  相似文献   
8.
9.
10.

Background

Health-related quality of life (HRQOL) is a critical aspect to consider when making treatment decisions for patients with non-Hodgkin-lymphoma (NHL). This international study by the European Organisation for Research and Treatment of Cancer (EORTC) tested the psychometric properties of two newly developed measures for patients with high-grade (HG)- and low-grade (LG)-NHL: the EORTC QLQ-NHL-HG29 and the EORTC QLQ-NHL-LG20 to supplement the core questionnaire (EORTC QLQ-C30).

Methods

Overall, 768 patients with HG-NHL (N = 423) and LG-NHL (N = 345) from 12 countries completed the QLQ-C30, QLQ-NHL-HG29/QLQ-NHL-LG20 and a debriefing questionnaire at baseline, and a subset at follow-up for either retest (N = 125/124) or responsiveness to change (RCA; N = 98/49).

Results

Confirmatory factor analysis showed an acceptable to good fit of the 29 items of the QLQ-NHL-HG29 on its five scales (symptom burden [SB], neuropathy, physical condition/fatigue [PF], emotional impact [EI], and worries about health/functioning [WH]), and of the 20 items of the QLQ-NHL-LG20 on its four scales (SB, PF, EI, and WH). Completion took on average 10 minutes. Test–retest reliability, convergent validity, known-group comparisons, and RCA find satisfactory results of both measures. A total of 31%–78% of patients with HG-NHL and 22%–73% of patients with LG-NHL reported symptoms and/or worries (e.g., tingling in hands/feet, lack of energy, and worries about recurrence). Patients reporting symptoms/worries had substantially lower HRQOL compared to those without.

Discussion

The use of the EORTC QLQ-NHL-HG29 and QLQ-NHL-LG20 questionnaires in clinical research and practice will provide clinically relevant data to better inform treatment decision-making.

Plain language summary

  • The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group developed two questionnaires.
  • These questionnaires measure health-related quality of life.
  • The questionnaires are for patients with high-grade or low-grade non-Hodgkin lymphoma.
  • They are called the EORTC QLQ-NHL-HG29 and QLQ-NHL-LG20.
  • The questionnaires are now internationally validated.
  • This study demonstrates that the questionnaires are reliably and valid, which are important aspects of a questionnaire.
  • The questionnaires can now be used in clinical trials and practice.
  • With the information gathered from the questionnaires, patients and clinicians can better evaluate treatments and discuss the best choice for a patient.
  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号